OSI PHARMACEUTICALS INC
S-8, EX-23.1, 2000-07-26
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: OSI PHARMACEUTICALS INC, S-8, EX-5, 2000-07-26
Next: ENCIBAR INC, 10QSB, 2000-07-26



<PAGE>   1

                                                                    EXHIBIT 23.1

                         CONSENT OF INDEPENDENT AUDITORS

The Board of Directors
OSI Pharmaceuticals, Inc.:


We consent to the use of our report dated December 22, 1999, incorporated herein
by reference.

                                                                       KPMG LLP

Melville, New York
July 25, 2000



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission